Vanguard Group »

Miragen Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $65M 3.0M 21.78
2023-09-30 $38M 2.4M 15.34
2023-06-30 $62M 2.6M 23.79
2023-03-31 $54M 2.1M 25.44
2022-12-31 $62M 2.1M 29.21
2022-06-30 $16M 1.4M 11.57
2022-03-31 $17M 941k 18.49
2021-09-30 $7.6M 462k 16.45
2021-06-30 $6.4M 354k 18.07
2021-03-31 $2.6M 169k 15.29